Interstitial lung disease and lung transplantation

Interstitial hing disease (ILD) comprises a group of heterogenous disorders that may be associated with progressive respiratory failure that eventually results in death. While current medical therapies have been successful in certain patients with ELD, there remains a subset of patients who continue to progress despite these therapies. In these patients, lung transplantation may provide an alternative therapeutic option. This review will discuss the newest developments in the field of lung transplantation and interstitial hing disease. Specifically, this review will discuss the impact of the new donor hing allocation system in the United States on patients with HD, the most recent International Society of Heart and Lung Transplantation guidelines for selection of lung transplant recipients the types of lung transplant procedure options and outcomes after transplantation. The most common medical complications associated with lung transplantation will also be discussed.